Neutralizing anti-SARS-CoV-2 antibodies
US12060411B2 · kind B2 · utility
0Cited by
2References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 13, 2022 |
| Grant date | Aug 13, 2024 |
| Priority date | — |
| Expiry date | Jan 13, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure provides novel neutralizing anti-SARS-CoV-2 antibodies or antigen-binding fragments thereof. The disclosed anti-SARS-CoV-2 antibodies constitute a novel therapeutic strategy in protection from SARS-CoV-2 infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.